LP s obsahem pembrolizumabu 2026
Original notice title
Czechia – Antineoplastic agents – LP s obsahem pembrolizumabu 2026
Opportunity Score
Why this score?
Opportunity
60 / 100
Complexity
30 / 100
Risk factors
Eligibility criteria and required documents are not specified in the notice; bidders may be disqualified if they fail t...
Award based solely on lowest price may lead to unsustainable pricing or reduced profit margins.
Submission deadline in 7 days
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Overview
Moderate opportunityKey Facts
- CZK 497.3M estimated value
- Supplies contract
- 1 lot
- Duration 36 MONTH
- Repeated deliveries of medicinal products containing the active substance pembrolizumab.
- Supply to Fakultní nemocnice Olomouc, Olomouc region, Czech Republic.
Show full summary
Single lot tender for repeated supply of pembrolizumab-containing medicinal products to Fakultní nemocnice Olomouc over 36 months. Estimated value 497,272,797 CZK. Award based solely on lowest price. Open procedure, electronic submission required. Place of performance: Olomouc region, Czech Republic. No selection criteria or required documents specified in the notice.
Risks
Eligibility criteria and required documents are not specified in the notice; bidders may be disqualified if they fail t...
Award based solely on lowest price may lead to unsustainable pricing or reduced profit margins.
Submission deadline in 7 days
Analysis may be incomplete
Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.
Key Requirements
Technical
- Supply of medicinal products with active substance pembrolizumab.
- Contract duration 36 months.
Administrative
- Submission of bid via electronic system at Open portal
Requirements may be incomplete.
Award Criteria
Lot 1
Buyer
Name
Fakultní nemocnice Olomouc
Location
Olomouc - Nová Ulice, CZE
Website
Buyer profile
Identifier
00098892
Activity
Health
Lots (1)
LOT-0001
LP s obsahem pembrolizumabu 2026
Repeated deliveries of medicinal products containing the active substance pembrolizumab.
CZK 497.3M
Estimated value
Location
Duration
Category
Selection criteria
Deadline
Award details
Value note
Show original TED data
Original TED description
Předmětem veřejné zakázky jsou opakující se dodávky léčivých přípravků s obsahem účinné látky pembrolizumab.
Procurement Details
- Publication date
- 11 Jun 2026
- Notice type
- Contract notice — standard
- Languages
- Czech
Reference metadata
- Notice subtype
- 16
- Notice version
- 1
- Legal basis
- 32014L0024
Reference IDs
- Tender ID
- 405254-2026
Documents (1)
Similar tenders
Estonia – Underwear – Termopesu ostmine
Poland – Hire of industrial vehicles with driver – Kompleksowa obsługa placów składowych i transportu wewnętrznego na powierzchni (w tym kopalnianych sieci kolei wąskotorowych) na rzecz Polskiej Grupy Górniczej S.A. KWK Murcki - Staszic
France – Development services of real estate – SELECTION D'UN PROJET POUR LA REALISATION D'UN ENSEMBLE IMMOBILIER DE 28 LOGEMENTS COLLECTIFS A CHATENAY-MALABRY (92) EN CPI
Poland – Pipeline, piping, pipes, casing, tubing and related items – „Dostawy rur z tworzyw sztucznych dla Południowego Koncernu Węglowego S.A.”
Austria – Construction supervision services – A01 GEN Knoten Linz – Knoten Haid + A01 ASt Traun/Haid - Örtliche Bauaufsicht E&M
Czechia – Diagnostic agents – Dodávky ZP_IVD – Reagencie a spotřební materiál pro sekvenační analýzu
Opportunity Score
Why this score?
Opportunity
60 / 100
Complexity
30 / 100
Risk factors
Eligibility criteria and required documents are not specified in the notice; bidders may be disqualified if they fail t...
Award based solely on lowest price may lead to unsustainable pricing or reduced profit margins.
Submission deadline in 7 days
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications